Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy

Autor: Laura A.M. van Lieshout, Malou E. Gelderblom, Joanne A. de Hullu, Regina The, Alexandra A. van Ginkel, Anke J.M. Oerlemans, Kirsten M.W.H. Smeets, Malou P.H. Schreurs, Jurgen M.J. Piek, Rosella P.M.G. Hermens

Publikováno v: American Journal of Obstetrics and Gynecology, 226, 2, pp. 234.e1-234.e14
American Journal of Obstetrics and Gynecology, 226, 234.e1-234.e14

Background The discovery of the Fallopian tube epithelium as origin of high grade serous ovarian cancer has brought a new option for ovarian cancer prevention. As the Fallopian tubes have no known function after completion of childbearing, they can b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14eed9633ab1266f9cc72326eb644c38
https://doi.org/10.1016/j.ajog.2021.09.010

Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.

Autor: van Weelden WJ; Department of Obstetrics and Gynaecology, Radboud Institute of Health Sciences, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: willemjan.vanweelden@radboudumc.nl., Lalisang RI; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., Bulten J; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Lindemann K; Division of Medicine, Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., van Beekhuizen HJ; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands., Trum H; Center for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, the Netherlands., Boll D; Department of Gynaecology, Catharina Hospital, Eindhoven, the Netherlands., Werner HMJ; GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Obstetrics and Gynecology, Maastricht University Medical Center+, Maastricht, the Netherlands., van Lonkhuijzen LRCW; Department of Gynaecology and Obstetrics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Yigit R; Department of Obstetrics and Gynecology, University Medical Center Groningen, Groningen, the Netherlands., Forsse D; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway., Witteveen PO; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Galaal K; Royal Cornwall Hospital NHS Trust, Truro, Cornwall, United Kingdom., van Ginkel A; Department of Obstetrics and Gynecology, Rijnstate Hospital, Arnhem, the Netherlands., Bignotti E; Division of Obstetrics and Gynecology, A. Nocivelli Institute for Molecular Medicine, ASST Spedali Civili di Brescia, Brescia, Italy., Weinberger V; Department of Obstetrics and Gynecology, Masaryk University and University Hospital Brno, Czech Republic., Sweegers S; Department of Obstetrics and Gynaecology, Radboud Institute of Health Sciences, Radboud university medical center, Nijmegen, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Cabrera S; Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Snijders MPLM; Department of Obstetrics and Gynecology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Inda MA; Molecular Pathway Diagnostics, Philips, Eindhoven, the Netherlands., Eriksson AGZ; Division of Medicine, Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway., Krakstad C; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Romano A; GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Obstetrics and Gynecology, Maastricht University Medical Center+, Maastricht, the Netherlands., van de Stolpe A; Molecular Pathway Diagnostics, Philips, Eindhoven, the Netherlands., Pijnenborg JMA; Department of Obstetrics and Gynaecology, Radboud Institute of Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.

Publikováno v: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Oct; Vol. 225 (4), pp. 407.e1-407.e16. Date of Electronic Publication: 2021 May 19.